478 related articles for article (PubMed ID: 25283820)
1. H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis.
Nandar W; Neely EB; Simmons Z; Connor JR
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2413-26. PubMed ID: 25283820
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the HFE gene is associated with altered brain iron profiles and increased oxidative stress in mice.
Nandar W; Neely EB; Unger E; Connor JR
Biochim Biophys Acta; 2013 Jun; 1832(6):729-41. PubMed ID: 23429074
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences.
Wang XS; Lee S; Simmons Z; Boyer P; Scott K; Liu W; Connor J
J Neurol Sci; 2004 Dec; 227(1):27-33. PubMed ID: 15546588
[TBL] [Abstract][Full Text] [Related]
4. H63D HFE polymorphisms are associated with increased disease duration and decreased muscle superoxide dismutase-1 expression in amyotrophic lateral sclerosis patients.
Su XW; Lee SY; Mitchell RM; Stephens HE; Simmons Z; Connor JR
Muscle Nerve; 2013 Aug; 48(2):242-6. PubMed ID: 23813494
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
6. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
7. Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability.
Liu Y; Lee SY; Neely E; Nandar W; Moyo M; Simmons Z; Connor JR
J Biol Chem; 2011 Apr; 286(15):13161-70. PubMed ID: 21349849
[TBL] [Abstract][Full Text] [Related]
8. Statins accelerate disease progression and shorten survival in SOD1(G93A) mice.
Su XW; Nandar W; Neely EB; Simmons Z; Connor JR
Muscle Nerve; 2016 Aug; 54(2):284-91. PubMed ID: 26799243
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
10. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
11. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
[TBL] [Abstract][Full Text] [Related]
12. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Cai M; Lee KW; Choi SM; Yang EJ
Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
[TBL] [Abstract][Full Text] [Related]
14. Iron accumulation promotes TACE-mediated TNF-α secretion and neurodegeneration in a mouse model of ALS.
Lee JK; Shin JH; Gwag BJ; Choi EJ
Neurobiol Dis; 2015 Aug; 80():63-9. PubMed ID: 26002422
[TBL] [Abstract][Full Text] [Related]
15. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
Shan X; Vocadlo D; Krieger C
Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
17. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
18. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities.
Tokuda E; Okawa E; Watanabe S; Ono S; Marklund SL
Neurobiol Dis; 2013 Jun; 54():308-19. PubMed ID: 23321002
[TBL] [Abstract][Full Text] [Related]
20. HFE p.H63D polymorphism does not influence ALS phenotype and survival.
Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Monsurrò MR; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Nilo R; Giannini F; Mandrioli J; Tanel R; Murru MR; Mandich P; Zollino M; Conforti FL; Penco S; ; ; Brunetti M; Barberis M; Restagno G
Neurobiol Aging; 2015 Oct; 36(10):2906.e7-11. PubMed ID: 26174855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
